H.R. 3 - Stand Up For Patients: Reject Foreign Reference Pricing

Stand with patients, doctors, and California’s innovative life sciences sector by telling Congress to reject H.R. 3, a flawed proposal that would bring foreign drug price controls to the U.S. and cripple innovation. The implementation of foreign price controls would reduce the number of innovative treatments and cures brought to American patients and eliminate over 190,000 biotech R&D jobs nationwide.

We can’t let that happen. Send a message to your Representative to make sure H.R. 3 does not pass.

Take Action Here

Tell California’s Tax and Budget Leaders to Restore R&D Tax Credits

While Hollywood helped entertain us during difficult times, California life sciences have played a critical role combatting COVID-19 and helping reopen the state. California​ policymakers have since passed $180 million in NEW film tax credits while failing to restore critical R&D tax credits for the life sciences.

Without these R&D tax credits, California runs the risk of losing its vibrant R&D ecosystem.

Tell California’s tax and budget leaders to restore R&D tax credits NOW.

Take Action Here


The California Life Sciences State Political Action Committee (CLSAPAC) is a bipartisan state political action committee established to solicit voluntary political contributions. The CLSAPAC enables companies and individuals to combine their resources to support state-level candidates who demonstrate a dedication to understanding California’s biomedical industry, encouraging the industry to flourish in the state, and fostering drug, device and diagnostics innovation. Unlike federal law, corporations are allowed under California law to make political contributions to a state PAC.

Learn More and Donate Here

Contact the Federal Team

Oliver Rocroi
Vice President, Federal Government Relations & External Affairs